clorox_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF
1934
Date of Report (Date
of Earliest Event Reported): May 3, 2010
THE CLOROX COMPANY
(Exact name of registrant as
specified in its charter)
Delaware
(State or other
jurisdiction of
incorporation or
organization)
| 1-07151 |
31-0595760 |
| (Commission File |
(I.R.S. Employer |
| Number) |
Identification
No.) |
1221 Broadway, Oakland,
California 94612-1888
(Address of principal executive
offices) (Zip code)
(510) 271-7000
(Registrant's telephone number, including area
code)
__________________________________________________
(Former name or
former address, if changed since last report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see
General Instruction A.2.)
[ ] Written
communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial
Condition
On May 3, 2010, The Clorox Company (the “Company”) issued a press release
announcing its financial results
for its second quarter ended
December 31, 2009. The full text of the press release is attached hereto as
Exhibit 99.1 and is incorporated herein by reference.
This information shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), or incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.
Item 7.01 Regulation FD Disclosure
Attached hereto as Exhibit 99.2 and
incorporated herein by reference is supplemental financial information.
Item 9.01 Financial Statements and Exhibits
|
|
(d) |
Exhibits |
| |
|
| |
Exhibit |
|
Description |
|
|
|
99.1 |
Press Release dated May 3, 2010 of The
Clorox Company |
|
|
99.2 |
Supplemental information regarding financial
results |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
| |
THE CLOROX COMPANY |
|
| |
|
|
|
| |
|
|
|
| Date:
May 3, 2010 |
By: |
/s/ Laura
Stein |
|
| |
|
Senior Vice President – |
|
|
|
|
General Counsel |
|
THE CLOROX COMPANY
FORM 8-K
INDEX TO EXHIBITS
| Exhibit |
Description |
| 99.1 |
Press
Release dated May 3, 2010 of The Clorox Company |
| 99.2 |
Supplemental Information |